Your shopping cart is currently empty

Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 1-2 weeks | 1-2 weeks | |
| 50 mg | $1,980 | 1-2 weeks | 1-2 weeks | |
| 100 mg | $2,500 | 1-2 weeks | 1-2 weeks |
| Description | Theliatinib (Xiliertinib) tartrate is a potent and highly selective EGFR inhibitor with ATP-competitive and orally active properties, showing a K_i of 0.05 nM and an IC_50 of 3 nM for EGFR, and an IC_50 of 22 nM for the EGFR T790M/L858R mutant, with over 50-fold selectivity for EGFR compared to other kinases. |
| Synonyms | Xiliertinib tartrate ; HMPL-309 tartrate, Xiliertinib tartrate, HMPL-309 tartrate |
| Molecular Weight | 592.6 |
| Formula | C29H32N6O8 |
| Cas No. | 2413487-72-4 |
| Smiles | [C@@H]([C@H](C(O)=O)O)(C(O)=O)O.N(C=1C2=C(C=C(OC)C(NC(=O)N3C[C@]4([C@@](C3)(CCN4C)[H])[H])=C2)N=CN1)C5=CC(C#C)=CC=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.